Vasomotor Symptom
Hormone therapy use higher among midlife active-duty servicewomen, but gaps remain
Use of menopausal hormone therapy among midlife active-duty servicewomen in the U.S. is twice as high as the general population but lower than women veterans, suggesting those who may derive the most benefit from HT are not receiving it.
Frequent, persistent hot flashes associated with 50% increased risk for diabetes
Women with frequent and persistent hot flashes and night sweats during the menopause transition are at increased risk for developing diabetes compared with women who do not experience vasomotor symptoms, researchers reported.
Making menopause mainstream: A conversation with Monica Christmas, MD, FACOG, MSCP
Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.
Poor hot flash documentation in primary care setting leaves many midlife women untreated
Many postmenopausal women self-reported moderate or higher vasomotor symptoms in the primary care setting but remained untreated due to lack of electronic health record documentation, researchers reported.
Hormone therapy use among menopausal women continues to decline, despite proven safety
CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.
VIDEO: ‘Less than 1%’ of federal funding goes to menopause research, prompting new program
CHICAGO — In this Healio video exclusive, Susan D. Reed, MD, MPH, MS, past president of The Menopause Society, highlights a new pilot program created to improve funding for research in menopause health, with up to four awards of $25,000 each.
VIDEO: Three takeaways on cognition and brain health during menopause
CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.
Clinicians ‘should be open’ to menopausal hormone therapy beyond age 65 years
CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.
Physical activity tied to greater odds of objective, subjective hot flashes
Acute increases in physical activity were associated with greater odds of objective and subjective hot flashes during waking and sleeping periods, according to findings published in Menopause.
Menopause transition does not increase risk for depressive symptoms for all women
Women are not universally at risk for depressive symptoms during menopause transition, but providers should be aware of risk factors and treat mental health disorders promptly, according to a review published in The Lancet.